FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130314540> ?p ?o ?g. }

• W2130314540 endingPage "1201" @default.
• W2130314540 startingPage "1201" @default.
• W2130314540 abstract "<h3>Objective</h3> To compare the occurrence of normal visual field (VF) test results following 2 vs 3 consecutive, abnormal, reliable test results in the Ocular Hypertension Treatment Study. <h3>Methods</h3> The Ocular Hypertension Treatment Study is a prospective, multicenter follow-up study as part of a longitudinal randomized clinical trial. Sixty-four (68 eyes) of 1636 participants developed a VF primary open-angle glaucoma (POAG) end point. We compared the proportion of normal VF test results after a VF POAG end point among eyes whose VF abnormality was confirmed by 2 (n = . eyes) vs 3 (n = 59 eyes) consecutive, abnormal, reliable VF test results. <h3>Results</h3> The proportion of VF test results that were normal subsequent to a VF POAG end point in eyes whose abnormality was confirmed by 2 consecutive, abnormal, reliable test results was significantly higher (73 [66%] of 110) compared with eyes whose abnormality was confirmed by 3 consecutive, abnormal, reliable test results (46 [12%] of 381) (<i>P</i> = .01). <h3>Conclusions</h3> A VF POAG end point confirmed by 3 consecutive, abnormal, reliable VF test results appears to have greater specificity and stability than either 1 or 2 consecutive, abnormal, reliable VF test results. However, some eyes whose VF POAG end point was confirmed by 3 consecutive, abnormal, reliable test results nonetheless had 1 or more normal test results on follow-up." @default.
• W2130314540 created "2016-06-24" @default.
• W2130314540 creator A5014294821 @default.
• W2130314540 creator A5029120994 @default.
• W2130314540 creator A5041865885 @default.
• W2130314540 creator A5059923040 @default.
• W2130314540 creator A5067140588 @default.
• W2130314540 creator A5067860378 @default.
• W2130314540 creator A5082770399 @default.
• W2130314540 date "2005-09-01" @default.
• W2130314540 modified "2023-09-23" @default.
• W2130314540 title "Normal Visual Field Test Results Following Glaucomatous Visual Field End Points in the Ocular Hypertension Treatment Study" @default.
• W2130314540 cites W1514230101 @default.
• W2130314540 cites W173097063 @default.
• W2130314540 cites W1893258488 @default.
• W2130314540 cites W1982787778 @default.
• W2130314540 cites W198356982 @default.
• W2130314540 cites W1994447302 @default.
• W2130314540 cites W2014388846 @default.
• W2130314540 cites W2018415881 @default.
• W2130314540 cites W2020396326 @default.
• W2130314540 cites W2026209674 @default.
• W2130314540 cites W2028029276 @default.
• W2130314540 cites W2035819222 @default.
• W2130314540 cites W2037447746 @default.
• W2130314540 cites W205472006 @default.
• W2130314540 cites W2061841032 @default.
• W2130314540 cites W2065289190 @default.
• W2130314540 cites W2070161732 @default.
• W2130314540 cites W2080185087 @default.
• W2130314540 cites W2083405530 @default.
• W2130314540 cites W2090432035 @default.
• W2130314540 cites W2094803132 @default.
• W2130314540 cites W2095613892 @default.
• W2130314540 cites W2100373472 @default.
• W2130314540 cites W2104729156 @default.
• W2130314540 cites W2110897487 @default.
• W2130314540 cites W2140594570 @default.
• W2130314540 cites W2143189496 @default.
• W2130314540 cites W2170354259 @default.
• W2130314540 cites W2322543443 @default.
• W2130314540 cites W25112218 @default.
• W2130314540 cites W2616044243 @default.
• W2130314540 cites W2616439427 @default.
• W2130314540 cites W4298123400 @default.
• W2130314540 cites W75886960 @default.
• W2130314540 doi "https://doi.org/10.1001/archopht.123.9.1201" @default.
• W2130314540 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1828122" @default.
• W2130314540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16157799" @default.
• W2130314540 hasPublicationYear "2005" @default.
• W2130314540 type Work @default.
• W2130314540 sameAs 2130314540 @default.
• W2130314540 citedByCount "37" @default.
• W2130314540 countsByYear W21303145402013 @default.
• W2130314540 countsByYear W21303145402014 @default.
• W2130314540 countsByYear W21303145402017 @default.
• W2130314540 countsByYear W21303145402018 @default.
• W2130314540 countsByYear W21303145402019 @default.
• W2130314540 countsByYear W21303145402020 @default.
• W2130314540 countsByYear W21303145402021 @default.
• W2130314540 countsByYear W21303145402022 @default.
• W2130314540 crossrefType "journal-article" @default.
• W2130314540 hasAuthorship W2130314540A5014294821 @default.
• W2130314540 hasAuthorship W2130314540A5029120994 @default.
• W2130314540 hasAuthorship W2130314540A5041865885 @default.
• W2130314540 hasAuthorship W2130314540A5059923040 @default.
• W2130314540 hasAuthorship W2130314540A5067140588 @default.
• W2130314540 hasAuthorship W2130314540A5067860378 @default.
• W2130314540 hasAuthorship W2130314540A5082770399 @default.
• W2130314540 hasBestOaLocation W21303145401 @default.
• W2130314540 hasConcept C118487528 @default.
• W2130314540 hasConcept C118552586 @default.
• W2130314540 hasConcept C2524010 @default.
• W2130314540 hasConcept C2776058522 @default.
• W2130314540 hasConcept C2776148792 @default.
• W2130314540 hasConcept C2776521421 @default.
• W2130314540 hasConcept C2778527774 @default.
• W2130314540 hasConcept C2781283680 @default.
• W2130314540 hasConcept C2987804222 @default.
• W2130314540 hasConcept C33923547 @default.
• W2130314540 hasConcept C50965678 @default.
• W2130314540 hasConcept C71924100 @default.
• W2130314540 hasConceptScore W2130314540C118487528 @default.
• W2130314540 hasConceptScore W2130314540C118552586 @default.
• W2130314540 hasConceptScore W2130314540C2524010 @default.
• W2130314540 hasConceptScore W2130314540C2776058522 @default.
• W2130314540 hasConceptScore W2130314540C2776148792 @default.
• W2130314540 hasConceptScore W2130314540C2776521421 @default.
• W2130314540 hasConceptScore W2130314540C2778527774 @default.
• W2130314540 hasConceptScore W2130314540C2781283680 @default.
• W2130314540 hasConceptScore W2130314540C2987804222 @default.
• W2130314540 hasConceptScore W2130314540C33923547 @default.
• W2130314540 hasConceptScore W2130314540C50965678 @default.
• W2130314540 hasConceptScore W2130314540C71924100 @default.
• W2130314540 hasIssue "9" @default.
• W2130314540 hasLocation W21303145401 @default.
• W2130314540 hasLocation W21303145402 @default.
• W2130314540 hasLocation W21303145403 @default.

• next